Showing results (1-10 of 523) with videos related to
Sort By:
Pageof 53
Wiener Klinische Wochenschrift|November 4, 1988
[Defects in the prostaglandin system. VI. Acquired plasma factor defect]H Sinzinger, P Fitscha, F Rauscha, et al.Basic Research in Cardiology|November 1, 1988
Beneficial effect of PGI2 on circulating endothelial cellsH Sinzinger, F Rauscha, P Fitscha, et al.Thrombosis Research|June 15, 1988
Comparable effect of prostaglandin E1 in decreasing in vivo platelet deposition on human lesion sites after intravenous and intraarterial applicationH Sinzinger, J O'Grady, P Fitscha, et al.Biomedica Biochimica Acta|January 1, 1984
Is gamma-camera imaging of platelet deposition useful to assess the effectiveness of prostacyclin treatment?P Fitscha, J Kaliman, H SinzingerAmerican Journal of Hematology|May 1, 1985
Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular diseaseP Fitscha, J Kaliman, H SinzingerProstaglandins, Leukotrienes, and Medicine|September 1, 1982
Hypertension and beneficial treatment with beta-blocking agents does not change the platelet sensitivity to the antiaggregatory prostaglandinsH Sinzinger, P Fitscha, J KalimanProstaglandins, Leukotrienes, and Essential Fatty Acids|March 1, 1989
Glucocorticoid-treatment does not influence the synthesis of thromboxane B2 and bicyclo-PGE2 in humansH Sinzinger, I Virgolini, F Rauscha, et al.Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 1, 1990
Effects of bopindolol on platelet function in hypertension at rest and during exerciseI Virgolini, P Fitscha, F Rauscha, et al.American Journal of Hypertension|February 1, 1991
Effects of isradipine on platelet function in hypertension at rest and during exerciseP Fitscha, I Virgolini, F Rauscha, et al.Prostaglandins|June 1, 1987
Prostaglandin I2 during radiolabelling improves recovery, but does not change platelet half-life and platelet uptake over active human lesion sitesH Sinzinger, P Fitscha, J KalimanPageof 53